➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Johnson and Johnson
McKinsey
Boehringer Ingelheim
Harvard Business School

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 6,429,259

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,429,259
Title: Water soluble polymeric complex comprising a conducting polymer and a biopolymer
Abstract:A molecular complex which comprises a biopolymer having a plurality of ionic functional groups and a conductive polymer having charges therein. The charges bind to the ionic functional groups to form the complex. The conductive polymer is selected from the group consisting essentially of polyaniline, polypyrrole, polythiophene, poly(phenylenevinylene) or poly(phenylene sulfide) and substituted versions thereof.
Inventor(s): Yang; Sze Cheng (Wakefield, RI), McCarthy; Patrick (Oakland, CA)
Assignee: The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI)
Application Number:09/825,074
Patent Claims:see list of patent claims

Details for Patent 6,429,259

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Grifols Usa, Llc PLASBUMIN albumin (human) SOLUTION 101138 1 1994-09-26   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
Baxalta Us Inc. FLEXBUMIN albumin human INJECTION, SOLUTION 101452 1 2014-07-31   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
Csl Behring Ag ALBURX albumin (human) SOLUTION 102366 1 2009-01-06   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
Grifols Usa, Llc ALBUTEIN albumin (human) INJECTION, SOLUTION 102478 1 2019-12-15   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
Grifols Usa, Llc HUMAN ALBUMIN GRIFOLS albumin (human) SOLUTION 103352 1 2003-06-11   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
Csl Behring Llc ALBUMINAR-25 albumin (human) SOLUTION 103955 1 2009-01-06   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
Octapharma Usa Inc ALBUMIN (HUMAN) albumin human SOLUTION 125154 1 2006-10-17   Start Trial The Board of Governors for Higher Education, State of Rhode Island and (N/A) (Providence, RI) 2020-04-03 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Johnson and Johnson
Colorcon
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.